Ingersoll Rand Acquires ILC Dover from New Mountain Capital

March 25, 2024

Ingersoll Rand Inc. agreed to acquire ILC Dover from New Mountain Capital for approximately $2.325 billion in upfront cash plus an earnout tied to 2024 operating metrics. The acquisition establishes a life sciences platform within Ingersoll Rand's P&ST segment, expands the company's presence in biopharmaceutical and medical device markets, and brings ILC's ~2,000+ employees and global manufacturing footprint into the business.

Buyers
Ingersoll Rand Inc.
Targets
ILC Dover
Sellers
New Mountain Capital
Industry
Medical Devices
Location
Delaware, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.